FDA to review inhalable caffeine


BOSTON (AP) - U.S. Food and Drug Administration officials plan to investigate whether inhalable caffeine sold in lipstick-sized canisters is safe for consumers and if its manufacturer was right to brand it as a dietary supplement.

AeroShot went on the market late last month in Massachusetts and New York, and it's also available in France. Consumers put one end of the grey-and-yellow plastic canister in their mouths and breathe in, releasing a fine powder that dissolves almost instantly.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

South Korea set to adjust medical reforms in bid to end walkout, say media reports
Explainer-India's Lok Sabha election 2024: What are the key issues?
Factbox-India’s Lok Sabha election 2024: What you need to know
Teenager charged with terrorism over Sydney bishop stabbing
UK PM Sunak to consult on tougher rules to combat 'sick note culture'
Weekly storage of natural gas in U.S. increases: EIA
U.S. stocks end mixed, S&P 500 down for 5th day
Canada to host UN event for global solution to end plastic pollution
U.S. stocks close mixed
India begins voting in gigantic election as Modi seeks historic third term

Others Also Read